In 2010, the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) Task Force on Myocardial Revascularization released guidelines on myocardial revascularization that state the following with respect to intraoperative graft flow patency assessment following bypass graft construction:

“Graft flow measurement, related to graft type, vessel size, degree of stenosis, quality of anastomosis and outflow area is useful at the end of surgery. Flow <20 ml/min and pulsatility index >5 predict technically inadequate grafts, mandating graft revision before leaving the operating theatre.” Section 10.2.2.

The significance of these guidelines cannot be overstated. It documents the ESC and EACTS Task Force on Myocardial Revascularization recognition of the importance of flow assessment during CABG. It has pushed intraoperative flow measurement within the European cardiovascular surgery community.

Transonic® intraoperative blood Flowmeters are the tools the cardiovascular surgical community needs to assess early graft patency and to mitigate some of the risks of cardiac surgery. Transonic volume flow measurements help ensure successful surgical outcomes by providing surgeons with immediate volume flow feedback following bypass construction.